doxifluridine has been researched along with Mouth Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, KP; Chang, YS; Chen, CC; Chen, LC; Hseuh, C; Liang, Y; Wu, CS | 1 |
1 other study(ies) available for doxifluridine and Mouth Neoplasms
| Article | Year |
|---|---|
Heterogeneous ribonucleoprotein K and thymidine phosphorylase are independent prognostic and therapeutic markers for oral squamous cell carcinoma.
Topics: Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; CASP8 and FADD-Like Apoptosis Regulating Protein; Female; Floxuridine; Heterogeneous-Nuclear Ribonucleoprotein K; Humans; Male; Middle Aged; Mouth Neoplasms; Prognosis; Retrospective Studies; Thymidine Phosphorylase | 2012 |